AngioDynamics Reports Fiscal 2019 Third Quarter Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
AngioDynamics (ANGO) Misses Q3 EPS by 3c, Revenues Miss; Reiterates FY19 EPS/Revenue Mid-Point Guidance Below Consensus
April 2, 2019 7:04 AM EDTAngioDynamics (NASDAQ: ANGO) reported Q3 EPS of $0.19, $0.03 worse than the analyst estimate of $0.22. Revenue for the quarter came in at $86.3 million versus the consensus estimate of $88.3 million.
Net sales of $86.3 million, an increase of 3.0% year over yearGross margin declined 10 basis points year over year to 54.1%GAAP EPS of $0.02 per share;... More